Share on StockTwits

Bioquell plc (LON:BQE) was upgraded by investment analysts at Investec to an “add” rating in a note issued to investors on Tuesday. The firm currently has a GBX 98 ($1.62) price objective on the stock, down from their previous price objective of GBX 133 ($2.20). Investec’s price target would suggest a potential upside of 10.11% from the stock’s previous close.

Shares of Bioquell plc (LON:BQE) traded down 1.55% on Tuesday, hitting GBX 89.10. The stock had a trading volume of 26,591 shares. Bioquell plc has a one year low of GBX 88.50 and a one year high of GBX 154.00. The stock has a 50-day moving average of GBX 94.8 and a 200-day moving average of GBX 115.4. The company’s market cap is £37.8 million.

Separately, analysts at N+1 Singer upgraded shares of Bioquell plc to a “buy” rating in a research note on Tuesday. They now have a GBX 112 ($1.85) price target on the stock.

Bioquell PLC is a holding company. It is engaged in the principal activities of designing, manufacturing and supplying of bio-decontamination and containment equipment, related products and services to the healthcare, life sciences and defense industries, and testing, regulatory and compliance services to a range of companies, including the aerospace, telecoms and defense industries.

Receive News & Ratings for Bioquell plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioquell plc and related companies with Analyst Ratings Network's FREE daily email newsletter.